GeoVax Labs market cap GOVX
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Nov 2, 2026
- $1.2M
- Highest close in our data
- $79.7M
- Aug 2022
GeoVax Labs is worth $1.2M at the close on Nov 2, 2026, at $0.16 a share.
That is down 91% over the last year and down 95% over five years.
Its highest close in our data was $79.7M in Aug 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.2M | $1.2M | $12.6M | −78% |
| 2025 | $5.4M | $4.7M | $24.9M | −77% |
| 2024 | $23.2M | $2.8M | $37.2M | +141% |
| 2023 | $9.6M | $8.4M | $24.6M | −42% |
| 2022 | $16.6M | $6M | $79.7M | −28% |
| 2021 | $23.1M | $12.6M | $37.6M | +79% |
| 2020 | $12.9M | $36.2K | $14M | +7457% |
| 2019 | $170.4K | $590 | $7.8M | −97% |
| 2018 | $6M | $4.3M | $8.4M | +8% |
| 2017 | $5.6M | $2.4M | $8.7M | +38% |
| 2016 | $4.1M | $3M | $5M | +33% |
| 2015 | $3.1M | $3.1M | $9.4M | −49% |
| 2014 | $6M | $6M | $15.1M | −62% |
| 2013 | $15.9M | $11M | $19.2M | −2% |
| 2012 | $16.2M | $16M | $24M | −15% |
| 2011 | $19.2M | $17.3M | $36.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest GeoVax Labs' size, closest first, today.
| Company | Market cap |
|---|---|
| GOVXGeoVax Labs | $1.2M |
| MTNBMatinas BioPharma | $1.3M |
| ARTLArtelo Biosciences | $1.1M |
| KAPAKairos Pharma, LTD. | $1.6M |
| OGENOragenics | $1.7M |
| ELABPMGC | $1.7M |
| LNAILunai Bioworks | $830.7K |
| JUNSJupiter Neurosciences | $1.8M |
| GNPXGenprex | $1.8M |
| NXTSNexentis Technologies | $772.3K |
| SILOSilo Pharma | $1.9M |
| Peer median | $1.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on GeoVax Labs
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.